1 hour ago | Daniel Paproth
* did an article on respiratory stocks that featured IVX....
https://**promotion blocked**/healt...piratory-stocks-to-get-you-feeling-breathless
There are more than a dozen ASX stocks focused on the respiratory space — from trying to tackle asthma
A * review of 13 small cap respiratory stocks has found that the majority are up year-on-year — led by one company that had a stellar 2018 financial year.
Invion (ASX:IVX), which is testing a drug called INV104, is up a huge 1358 per cent over the past 12 months, going from 0.2c to 3.5c earlier today:
https://**promotion blocked**/wp-content/uploads/2018/08/Share-Price-41.jpg
Invion shares (ASX:IVX) over the past year
The drug works by blocking the actions of leukotrienes, preventing the increased mucus production, inflammation and narrowing of the airways that occurs in asthma.
Add to My Watchlist
What is My Watchlist?
